Pramlintide
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
AstraZeneca · Phase 4 · Completed · Enrollment 33
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | Obesity + T2D | n/r | n/r | n/r | n/r |
| Pramlintide | Obesity + T2D | n/r | n/r | n/r | n/r |